Skip to content

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot Corporation logo
Cabot CorporationCBT
1.1×-0.3×
Travel + Leisure logo
Travel + LeisureTNL
+1.6×
Unifirst logo
UnifirstUNF
-0.2×-0.1×
HES
Hess MidstreamHESM
3.1×-0.1×
Carter's logo
Carter'sCRI
3.6×+0.8×
Harmonic logo
HarmonicHLIT
0.1×-2.0×

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's net debt?
ADMA Biologics (ADMA) reported net debt of $66.25M in Q1 2026.
How has ADMA Biologics's net debt changed year-over-year?
ADMA Biologics's net debt increased by 206.6% year-over-year, from -$62.14M to $66.25M.
What is the long-term trend for ADMA Biologics's net debt?
Over 5 years (2020 to 2025), ADMA Biologics's net debt has grown at a -28.6% compound annual growth rate (CAGR), from $41.75M to -$7.75M.
What does net debt mean?
Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.